These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9696487)

  • 21. Hepatitis C Virus Infection Is Positively Associated with Gallstones in Liver Cirrhosis.
    Zhang FM; Chen LH; Chen HT; Shan GD; Hu FL; Yang M; Chen WG; Xu GQ
    Digestion; 2016; 93(3):221-8. PubMed ID: 27093174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of host-related factors on the intensity of liver fibrosis in patients with chronic hepatitis C virus infection.
    Costa LB; Ferraz ML; Perez RM; Ferreira AS; Matos CA; Lanzoni VP; Silva AE
    Braz J Infect Dis; 2002 Oct; 6(5):219-24. PubMed ID: 12495603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.
    Hissar SS; Kumar M; Tyagi P; Goyal A; Suneetha PV; Agarwal S; Rastogi A; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2009 Apr; 24(4):581-7. PubMed ID: 19032460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c.
    Poynard T; Ratziu V; Charlotte F; Goodman Z; McHutchison J; Albrecht J
    J Hepatol; 2001 May; 34(5):730-9. PubMed ID: 11434620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiviral regimen complexity index as an independent predictor of sustained virologic response in patients with chronic hepatitis C.
    Galán RJ; Cidoncha EC; Martin MF; Rodriguez CC; Almeida CV; Verdugo RM
    J Manag Care Pharm; 2013; 19(6):448-53. PubMed ID: 23806058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study.
    Marcon PDS; Tovo CV; Kliemann DA; Fisch P; de Mattos AA
    World J Gastroenterol; 2018 Feb; 24(5):613-622. PubMed ID: 29434450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between histologic staging, hepatitis C virus genotypes and clinical features in HCV chronic hepatitis: evidence of a new pattern.
    Di Tommaso L; Macchia S; Morandi L; Leoncini S; Pession A; Dal Monte PR; Foschini MP
    Int J Surg Pathol; 2003 Jul; 11(3):197-204. PubMed ID: 12894351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of alcohol, cigarette smoking, and diabetes on occurrence of hepatocellular carcinoma in patients with transfusion-acquired hepatitis C virus infection who develop cirrhosis.
    Di Costanzo GG; De Luca M; Tritto G; Lampasi F; Addario L; Lanza AG; Tartaglione MT; Picciotto FP; Ascione A
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):674-9. PubMed ID: 18679071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of human immunodeficiency virus infection on the histological features of chronic hepatitis C: a case-control study. The MULTIVIRC group.
    Allory Y; Charlotte F; Benhamou Y; Opolon P; Le Charpentier Y; Poynard T
    Hum Pathol; 2000 Jan; 31(1):69-74. PubMed ID: 10665916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SEN virus infection influences the pathological findings in liver but does not affect the incidence of hepatocellular carcinoma in patients with chronic hepatitis C and liver cirrhosis.
    Moriyama M; Mikuni M; Matsumura H; Nakamura H; Oshiro S; Aoki H; Shimizu T; Yamagami H; Shioda A; Kaneko M; Tanaka N; Arakawa Y
    Liver Int; 2005 Apr; 25(2):226-35. PubMed ID: 15780043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained virologic response and IL28B single-nucleotide polymorphisms in patients with chronic hepatitis C treated with pegylated interferon alfa and ribavirin.
    Jabłonowska E; Piekarska A; Koślińska-Berkan E; Omulecka A; Szymańska B; Wójcik K
    Acta Biochim Pol; 2012; 59(3):333-7. PubMed ID: 22924160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural history of chronic hepatitis C.
    Pagliaro L; Peri V; Linea C; Cammà C; Giunta M; Magrin S
    Ital J Gastroenterol Hepatol; 1999; 31(1):28-44. PubMed ID: 10091101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users.
    Pol S; Lamorthe B; Thi NT; Thiers V; Carnot F; Zylberberg H; Berthelot P; Bréchot C; Nalpas B
    J Hepatol; 1998 Jun; 28(6):945-50. PubMed ID: 9672168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study.
    Benvegnù L; Fattovich G; Noventa F; Tremolada F; Chemello L; Cecchetto A; Alberti A
    Cancer; 1994 Nov; 74(9):2442-8. PubMed ID: 7922998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus.
    Mussini C; Lorenzini P; Puoti M; Lichtner M; Lapadula G; Di Giambenedetto S; Antinori A; Madeddu G; Cozzi-Lepri A; d'Arminio Monforte A; De Luca A;
    PLoS One; 2015; 10(12):e0140877. PubMed ID: 26640953
    [TBL] [Abstract][Full Text] [Related]  

  • 37.  Natural history of hepatitis C virus infection in a cohort of asymptomatic post-transfused subjects.
    Reggiardo MV; Fay F; Tanno M; García-Camacho G; Bottaso O; Ferretti S; Godoy A; Guerrita C; Paez M; Tanno F; Ruffinengo O; Benetti S; García Borrás SE; Rossi MC; Vorobioff J; Bessone F; Tanno H
    Ann Hepatol; 2012; 11(5):658-66. PubMed ID: 22947526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of early-untreated HIV infection on chronic hepatitis C in intravenous drug users: a case-control study.
    Serfaty L; Costagliola D; Wendum D; Picard O; Meyohas MC; Girard PM; Lebas J; Delamare C; Poupon R; Housset C
    AIDS; 2001 Oct; 15(15):2011-6. PubMed ID: 11600830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Profile and value of FIB-4 in patients with dual chronic hepatitis C and B.
    Liu CJ; Tseng TC; Yang WT; Su TH; Yang HC; Liu CH; Chen PJ; Chen DS; Kao JH
    J Gastroenterol Hepatol; 2019 Feb; 34(2):410-417. PubMed ID: 30151861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nitazoxanide for chronic hepatitis C.
    Nikolova K; Gluud C; Grevstad B; Jakobsen JC
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD009182. PubMed ID: 24706397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.